Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AgelessRx vs Effecty

By GLP-1 ScorecardUpdated

AgelessRx
Site position #17

Higher score

EffectyFactor scores not reassessed.
Site position #21

Lower score

Score comparison

AgelessRx has the higher recorded score — 84.3/100 to 83.7/100, but only just.

AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Conventional and microdose GLP-1 programs with continuing care; branded prescriptions involve a separate pharmacy payment. Effecty is close behind and may still be the better fit — see the factor split below.

Before you choose

AgelessRx does not publish a semaglutide price, so its AgelessRx review sets out what it does disclose, while the Effecty review explains the conditions attached to Effecty's figure. The semaglutide cost page compares published rates across the field. Ask AgelessRx for a written total before treating either one as the cheaper choice.

If neither one fits, AgelessRx vs Eloria and altRX vs Effecty compare each of them with another graded program, and the list of alternatives to AgelessRx ranks the programs closest to AgelessRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Found review covers one graded close to these two, at 83.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueAgelessRx +10
90
80
Dose & formulationEffecty +4
80
84
Clinical oversightEffecty +2
83
85
Labs & monitoringEffecty +2
82
84
FulfillmentEffecty +3
84
87
Contract termsEffecty +1
85
86
AgelessRx · top barEffecty · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAgelessRxEffecty
WeighScore84.3/10083.7/100
GradeBB
Site position#17#21
SemaglutideNot verified (current medication-specific quote required)$170/month before code; advertised $95 first month. Supply unconfirmed.
TirzepatideMicrodose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote required$235/month before code; advertised $160 first month. Supply unconfirmed.
CoverageAdvertises US service; confirm treatment-specific state availabilityNationwide shipping claimed; confirm treatment-specific eligibility.
Brand-name accessYesYes
Oral / sublingualYesNot confirmed
AgelessRx

Site position #17 · B

Strengths

  • Conventional and lower-dose GLP-1 programs advertised
  • Wegovy pens and oral-tablet consultations advertised
  • Continuing messaging and check-ins advertised

What to consider

  • Conventional medication-specific monthly quotes not verified
  • Microdose introduction renews as a two-month charge
  • Branded medication has a separate pharmacy bill
  • Treatment-specific state eligibility and assigned dispenser need confirmation
Effecty

Site position #21 · B

Factor scores not reassessed.

Strengths

  • Medication-specific billing terms
  • Dose-independent pricing advertised
  • Separate Wegovy offer published

What to consider

  • Selected total/supply unconfirmed
  • Prescription sales described as final
  • Assigned pharmacy and individual credentials unverified

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard